About
MediChain
マーク・ベイカー博士
マーク・ベイカー博士
-
MediChain is a UK based company which was founded in 2018 by CEO Dr. Mark Baker.
-
Dr. Mark Baker holds a PhD from Oxford University and a Master of Science in Immunology and Cell Biology from Imperial College London.
-
MediChain is a predictive analysis system developed with Oxford University "Athena AI", it has a sensitivity of more than 98.67% positive detection prediction results for COVID-19 infections, which can be used against global pandemics.
Click here for other MediChain staff introduction.
Dr. Mark Baker
CLDC Testing is a new testing method for detecting COVID-19 by using AI technology which analyzes your blood.
CLDC testing provides you cheap and speedy test for COVID-19.
With our unique testing method, the presence or absence of infection can be determined up to two weeks earlier than with the PCR test.
Company profile
Company Name
MediChain Asia Inc.
Address
Kagurazaka First Bldg. 5th
27 Nakazatocho, Shinjuku-ku, Tokyo 162-0804, Japan